JAMA Neurol Jama Neurology, 79, 3, pp. 228-243 Jama Neurology, 79, 228-243 Amyloid Biomarker Study Group 2022, ' Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum ', JAMA Neurology, vol. 79, no. 3, pp. 228-243 . https://doi.org/10.1001/jamaneurol.2021.5216 JAMA Neurology, 79(3), 228-243. American Medical Association JAMA neurology 79(3), 228-243 (2022). doi:10.1001/jamaneurol.2021.5216 Jansen, W J, Janssen, O, Tijms, B M, Vos, S J B, Ossenkoppele, R, Visser, P J & Amyloid Biomarker Study Group 2022, ' Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum ', JAMA Neurology, vol. 79, no. 3, pp. 228-243 . https://doi.org/10.1001/jamaneurol.2021.5216